1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Dian Diagnostics Group Co.,Ltd.
  6. Summary
    300244   CNE1000015N1

DIAN DIAGNOSTICS GROUP CO.,LTD.

(300244)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
05/16/2022 05/17/2022 05/18/2022 05/19/2022 05/20/2022 Date
33.25 32.31 32.15 32.37 32.11 Last
15380140 15263330 7712860 11029560 10480500 Volume
-4.84% -2.83% -0.50% +0.68% -0.80% Change
Estimated financial data (e)
Sales 2022 16 556 M 2 474 M 2 474 M
Net income 2022 1 841 M 275 M 275 M
Net Debt 2022 18,7 M 2,80 M 2,80 M
P/E ratio 2022 10,8x
Yield 2022 1,20%
Sales 2023 16 141 M 2 412 M 2 412 M
Net income 2023 1 668 M 249 M 249 M
Net cash position 2023 3 195 M 477 M 477 M
P/E ratio 2023 12,0x
Yield 2023 1,28%
Capitalization 19 923 M 2 977 M 2 977 M
EV / Sales 2022 1,20x
EV / Sales 2023 1,04x
Nbr of Employees 11 123
Free-Float 35,4%
More Financials
Company
Dean Diagnostic Technology Group Co., Ltd. is a company providing integrated solutions for medical diagnosis. The Company's main business involves inspection services, product services, health management, judicial expertise, contract research organization (CRO), cold chain logistics and other fields. The Company's business is mainly oriented to medical and health institutions at all levels, such as various general... 
Sector
Healthcare Facilities & Services
Calendar
05/20 | 02:00amShareholder meeting
More about the company
Ratings of Dian Diagnostics Group Co.,Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about DIAN DIAGNOSTICS GROUP CO.,LTD.
04/26Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended Ma..
CI
04/18Dian Diagnostics Group Co.,Ltd. Proposes Final Cash Dividend for 2021
CI
04/15Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Full Year Ended Decemb..
CI
02/21Asian Games Hangzhou appoints official health testing services supplier
AQ
2021Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended Sept..
CI
2021Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 3..
CI
2021Dian Diagnostics Group Co.,Ltd. Announces 2020 Final Profit Distribution Plan to Be Imp..
CI
2021Dian Diagnostics Group Co.,Ltd. Approved Final Cash Dividend for 2020
CI
2021Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended Ma..
CI
2021Dian Diagnostics Group Co.,Ltd. Proposes Final Cash Dividend for 2020
CI
2021Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Full Year Ended Decemb..
CI
2021China's coronavirus anxiety super-charges testing business in holiday season
RE
2020Dian Diagnostics Group Co.,Ltd. agreed to acquire 25% stake in Guangzhou Dihuixin Medic..
CI
2020Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended Sept..
CI
2020Dian Diagnostics Group Co.,Ltd. Announces Board Elations
CI
More news
News in other languages on DIAN DIAGNOSTICS GROUP CO.,LTD.
04/26Dian Diagnostics Group Co.,Ltd. annonce ses résultats pour le premier trimestre clos le..
04/18Dian Diagnostics Group Co.,Ltd. propose un dividende final en espèces pour 2021
04/15Dian Diagnostics Group Co.,Ltd. annonce ses résultats pour l'année complète se terminan..
2021Dian Diagnostics Group Co.,Ltd. annonce la mise en œuvre du plan final de distribution ..
2021Dian Diagnostics Group Co.,Ltd. Approbation du dividende final en espèces pour 2020
More news
Chart DIAN DIAGNOSTICS GROUP CO.,LTD.
Duration : Period :
Dian Diagnostics Group Co.,Ltd. Technical Analysis Chart | 300244 | CNE1000015N1 | MarketScreener
Technical analysis trends DIAN DIAGNOSTICS GROUP CO.,LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 32,11 CNY
Average target price 51,25 CNY
Spread / Average Target 59,6%
EPS Revisions
Managers and Directors
Bai Xing Huang Managing Director & Director
Fatt Heng Wong Chief Executive Officer
Yu Peng Shi Chief Financial Officer
Hai Bin Chen Chairman
Xiu Li Cheng Chairman-Supervisory Board